Indication
Esophageal Squamous Carcinoma
2 clinical trials
8 products
1 abstract
Clinical trial
A Multicenter, Open-label, Phase Ib/II Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy Versus Paclitaxel in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.Status: Not yet recruiting, Estimated PCD: 2027-04-01
Product
CisplatinProduct
DocetaxelProduct
SG001Product
PaclitaxelClinical trial
DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With Locally Advanced or Metastatic HER2 IHC2+/3+ Esophageal Squamous Cell CarcinomaStatus: Not yet recruiting, Estimated PCD: 2025-02-28
Product
RC48+PD-1+platinum-basedProduct
ToripalimabProduct
Nab-paclitaxelProduct
S-1